You are here

Jason Rush


Cao Z, Conway KL, Heath RJ, Rush JS, et al. Ubiquitin ligase TRIM62 regulates CARD9-mediated anti-fungal immunity and intestinal inflammation. Immunity. 2015 Oct 20;43(4):715-26.

Heath RJ, Goel G, Baxt LA, Rush JS, et al. RNF166 determines recruitment of adaptor proteins during antibacterial autophagy. Cell Rep. 2016 Nov 22;17(9):2183-2194.

Jason Rush, Ph.D.

Jason Rush is a research scientist II working in the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard under the direction of Thomas Sundberg. He is working to develop therapeutics for inflammatory bowel disease by targeting protein/protein interactions involved in innate immunity. 

Rush joined the Broad Institute in July 2014 after completing postdoctoral research in the labs of Andrew Phillips and Jo Handelsman exploring how small molecules influence microbial secondary metabolism. He holds a Ph.D. in chemistry from the University of California at Berkeley, where he worked with Carolyn Bertozzi to exploit a unique post-translational modification for protein engineering purposes. He also holds a B.S. in chemistry from the University of Michigan.

Contact Jason Rush via email at

January 2021